EUVIMEDEUVIMED entdecken
Crossref

Plasmodium falciparum acetyltransferase GCN5 acts as a dual regulator of essential glycolytic enzyme phosphoglycerate mutase

Ankita Tehlan, Poonam Nagar, Reena Prajapati, Krishanu Bhowmick, Amarjeet Kumar, Inderjeet Kaur, Naidu Subbarao, Suman Kumar Dhar iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Ankita Tehlan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India. Hauptthemen laut MEDLINE: Phosphoglycerate Mutase, Plasmodium falciparum, Protozoan Proteins, p300-CBP Transcription Factors. Die Arbeit nennt 94 Literaturangaben. Gefördert von: Anusandhan National Research Foundation (ANRF), Govt. of India: Sir J. C. Bose fellowship, Department of Science and Technology, SERB, Govt. of India (DPRP), Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysine acetylation is emerging as a key player in cellular regulation across species by controlling the fate of metabolic proteins as well as modulating gene expression via histone modification. Phosphoglycerate mutase, a conserved enzyme of the sole energy‐yielding pathway of glycolysis in the human malaria parasite Plasmodium falciparum , is indispensable for its growth. Here, we demonstrate that P. falciparum phosphoglycerate mutase PfPGM1 (phosphoglycerate mutase) is regulated via lysine acetylation. In mammalian cells, acetylation of phosphoglycerate mutase modulates its catalytic activity, although the acetyl transferase enzyme remains elusive. However, the parasites exhibit a unique way of regulating the fate of PfPGM1 via acetylation that modulates its stability, thus providing an increased protein pool for the rapid growth and proliferation of the parasites. We show that K100, a critical residue for PfPGM1 catalytic activity, is acetylated by the essential histone acetyltransferase PfGCN5. Downregulation of PfGCN5 through a knockdown approach in the parasites along with cycloheximide treatment indeed leads to a reduction of PfPGM1 protein. Additionally, PfGCN5 occupies the promoter of PfPGM1 in a stage‐specific manner, and downregulation of PfGCN5 protein leads to a reduced transcript level of PfPGM1. Collectively, our data highlight a dual regulation of PfPGM1 by PfGCN5 through acetylation of the protein as well as regulation of the transcription of the gene. Such dual control is not only rare but showcases the importance of the above two proteins and their potential as excellent targets against malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoglycerate MutasePlasmodium falciparumProtozoan Proteinsp300-CBP Transcription FactorsAcetylationHumansGlycolysisLysinePromoter Regions, GeneticAnimalsp300-CBP-Associated Factor

Stichwörter der Autor:innen

GCN5Plasmodium falciparumacetylationphosphoglycerate mutase (PGM)stability

Substanzen

Phosphoglycerate MutaseProtozoan Proteinsp300-CBP Transcription FactorsLysinep300-CBP-Associated Factor

Autor:innen und Institutionen

  • Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
  • Guru Gobind Singh Indraprastha University, New Delhi, India.
  • The Institute for Bioelectronic Medicine, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
  • School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India.
  • National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Department of Biotechnology, Central University of Haryana, Mahendergarh, India.

ORCID-Profile: Suman Kumar Dhar

Förderung

  • Anusandhan National Research Foundation (ANRF), Govt. of India: Sir J. C. Bose fellowship
  • Department of Science and Technology, SERB, Govt. of India (DPRP)
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Council of Medical Research, Govt of India

Zitieren

APA

Tehlan, A., Nagar, P., Prajapati, R., Bhowmick, K., Kumar, A., Kaur, I., Subbarao, N., & Dhar, S. K. (2025). Plasmodium falciparum acetyltransferase GCN5 acts as a dual regulator of essential glycolytic enzyme phosphoglycerate mutase. The FEBS Journal. https://doi.org/10.1111/febs.70164

Vancouver

Tehlan A, Nagar P, Prajapati R, Bhowmick K, Kumar A, Kaur I, et al. Plasmodium falciparum acetyltransferase GCN5 acts as a dual regulator of essential glycolytic enzyme phosphoglycerate mutase. The FEBS Journal. 2025. doi:10.1111/febs.70164

BibTeX
@article{Tehlan2025,
  author = {Tehlan, Ankita and Nagar, Poonam and Prajapati, Reena and Bhowmick, Krishanu and Kumar, Amarjeet and Kaur, Inderjeet and Subbarao, Naidu and Dhar, Suman Kumar},
  title = {Plasmodium falciparum acetyltransferase GCN5 acts as a dual regulator of essential glycolytic enzyme phosphoglycerate mutase},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70164}
}
Kostenlos starten →